Era Gorica, PhD, PharmD is an expert in Cardiology at University Hospital of Zurich (Switzerland). Era Gorica has authored 68 publications, the most recent in 2026. SLR score: 245 (community average: 125). How the SLR is computed.

LeadR Profile

Era Gorica, PhD, PharmD University Hospital of Zurich Switzerland
245 ScienceLeadR Reputation 245
Network Map

Cardiology

Subspecialties: Biochemistry - Genetics - Pharmacy

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2020 - 2026

Source: PubMed

Albanian University

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 68

Citations

Citations: 555 1st author: 11 Last author: 0 Unique author: 0


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
BET-induced metabolic reprogramming fuels inflammation at the vascular-fat interface in mice and patients with cardiometabolic disease.
PMID 42228564 — genes, blood, biological science disciplines, blood vessels
Cell Rep20260
Algae-Derived Bioactives Reprogram the Gut-SIRT1-Kisspeptin Axis in Polycystic Ovary Syndrome.
PMID 42188320 — pharmaceutical preparations, ovary, multiple chronic conditions, hormones, kisspeptins, polycystic ovary syndrome, gastrointestinal microbiome, microbiota, sirtuin 1
Mar Drugs20260
Phytochemical Profiling and Pharmacoinformatics Reveal Proliverenol from Phaleria macrocarpa as a Multi-Target Hepatoprotective Modulator of MAFLD.
PMID 41901336 — non-alcoholic fatty liver disease, multiple chronic conditions, liver, pharmacology, metabolomics, therapeutics, apoptosis, phytochemicals
Pharmaceuticals (Basel)20260
Precision Nutrition in Type 2 Diabetes Prevention Through Molecular Nutrigenomic and Epigenetic Modulation of Insulin Signaling and Glucose Metabolism.
PMID 41751766 — diabetes mellitus, genes, functional food, insulin resistance, insulin, diet, nutrigenomics, gene expression, diabetes mellitus, type 2, dietary patterns
Int J Mol Sci20260
Neurochemical Changes Following Botulinum Toxin Type A in Chronic Migraine: An LC-MS/MS and HPLC Evaluation of Plasma and Urinary Biomarkers.
PMID 41682889 — headache, migraine disorders, enzyme-linked immunosorbent assay, biomarkers, botulinum toxins, type a, botulinum toxins, therapeutics, glutamine, plasma
J Clin Med20260

LeadR Networks

Main global connection map